cancer

Latest stories

  • in Health care

    Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations

    by

    Beerse: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the European Commission (EC) has granted marketing authorisation for AKEEGA (niraparib and abiraterone acetate [AA]), in the form of a dual action tablet (DAT), given with prednisone or prednisolone, for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline […] More

  • in Health care

    Unhealthy diet may heighten risk of prostate cancer: Study

    by

    Adhering to healthy diets seems to have no effect on prostate cancer risk, but following an unhealthy diet might increase the risk of developing aggressive prostate cancer, according to a study published in BJU International. The study assessed the diets of 15,296 men recruited in Spain in from 1992-1996. Among these men, 609 prostate cancer […] More

  • in Health care

    Power of Reach: Why Celebrity Cancer Survivor Stories Matter?

    by

    Cancer survivors are people who battled the disease and came out alive from the life-threatening condition. Despite many innovations in medical science, cancer is still dreaded. The condition sees no class or creed and can happen to anyone irrespective of their lifestyle, medical history and economic situation. Celebrities who fight cancer tell us how common […] More

  • in Health care

    Vitamin D may play a role in prostate cancer disparities: Study

    by

    New research from Cedars-Sinai Cancer suggests that vitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with European American men. The multi-institutional study, published today in Cancer Research Communications, a journal of the American Association for Cancer Research (AACR), could pave the way for […] More

  • in Health care

    Merck-Moderna vaccine helps keep patients free from skin cancer

    by

    An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44 percent compared with Merck’s immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday. The findings suggest that adding a personalized cancer vaccine based on […] More

  • in Health care

    Depression negatively affects breast cancer patients’ survival: Study

    by

    Having depression before or after a breast cancer diagnosis was associated with a lower likelihood of survival, in a recent study. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. For the study, Bin Huang, DrPH, of the University of Kentucky Markey Cancer Center, and his colleagues […] More

  • in Health care

    Moderna, Merck cancer vaccine plus Keytruda delays skin cancer return

    Moderna, Merck cancer vaccine plus Keytruda delays skin cancer return

    by

    New Delhi: An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44 percent compared with Merck‘s immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday. The findings suggest that adding a personalized cancer vaccine […] More

  • in Health care

    Lower-Dose Regimens of Exemestane Effective in Postmenopausal Patients With Stage 0 to II ER-Positive Breast Cancer

    Lower-Dose Regimens of Exemestane Effective in Postmenopausal Patients With Stage 0 to II ER-Positive Breast Cancer

    by

    According to research reported in JAMA Oncology, based on findings from a phase IIb trial, 25 mg exemestane thrice weekly is noninferior to the standard dosing of 25 mg once daily pertaining to reduction of serum estradiol among postmenopausal patients with stage 0 to II estrogen receptor (ER)-positive breast cancer. Minimal effective dose is an […] More

Load More
Congratulations. You've reached the end of the internet.